Avid Bioservices, based in Tustin, California, specializes in the clinical and commercial manufacturing of biologics with 371 employees. They offer extensive services for biotechnology and biopharmaceutical industries, distributing products to over 90 countries.
Avid Bioservices (CDMO) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Avid Bioservices's actual EPS was -$0.27, missing the estimate of -$0.12 per share, resulting in a -125.19% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
